Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Loss of functional alpha-synuclein: a toxic event in Parkinson's disease?

Journal of Parkinson's disease - 1 Jan 2012

Kanaan Nicholas M, Manfredsson Fredric P

Abstract excerpt

The discovery that alpha-synuclein (α-syn) is the primary component of the neuropathological hallmarks of Parkinson's disease (PD) and the identification of α-syn mutations in numerous inherited forms of PD has positioned α-syn at the top of the list of important factors in the pathogenesis of PD. Based on the pathological accumulation of α-syn in the brains of patients, the field is currently focused on...

Topics

Animals
Brain
Humans
Lewy Bodies
Mutation
Neurons
Parkinson Disease
alpha-Synuclein

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23938255
DOI: 10.3233/JPD-012138
PMCID: PMC4736738

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of functional alpha-synuclein: a toxic event in Parkinson's disease?PMID 23938255Read ↗

Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.Semantic proximity Read ↗

Alpha-synuclein dysfunction in Lewy body diseases.Semantic proximity Read ↗

The good and bad of therapeutic strategies that directly target α‐synucleinSemantic proximity Read ↗

Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in NeurodegenerationSemantic proximity Read ↗

Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical ApplicationSemantic proximity Read ↗

Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications.Semantic proximity Read ↗

Alpha-synuclein: its biological function and role in neurodegenerative diseases.Semantic proximity Read ↗

Advances in understanding the function of alpha-synuclein: implications for Parkinson’s diseaseSemantic proximity Read ↗

Molecular mechanisms of alpha-synuclein neurodegeneration.Semantic proximity Read ↗

Navigating the Neurobiology of Parkinson’s: The Impact and Potential of α-SynucleinSemantic proximity Read ↗

The role of α-synuclein in neurodegenerative diseasesSemantic proximity Read ↗

In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.